2025 review “Could do better”. Stand out winner was #CPI with #FTC not far behind. Funds BlueWhale and JOCHM Income also did well. Steady as she goes from #RKW, #ONWD and #HRI A few small caps pregnant with performance for 26. #OBI, #CKT, #AFC #FCH, #hri Good Luck All

#VLX - Record H1 revenues and FY profits to be at top end of expectations. Strong balance sheet will fund further M&A and buy backs. Everything is looking good. Hats off to mgmt.

#ANG - Strong UK performance held back by weaker Europe. The new year has started positively despite the tough trading environment

#IPX - Outflows continue but mgmt believe that improved equity performance means they are past the worst...

#MARS - What a cracking trading update to wake up to Profits above top end and mgmt confident about future profit growth

#CAV - a really interesting day yesterday at the Cavendish conference. Thanks to all for making it happen. Great meeting with #FCH #ASAI #PRTC #KOO #FNTL

#CAML - Q3 trading in line. Proposed Cygnus Metals acquisition proceeding to plan “Q3 2026 was a positive period for CAML, with good progress on all of the main elements of the Company’s strategy."

#LIKE - Game over for Headlam as Likewise buys a number of assets from the and becomes the UK's largest floorcoverings company. Tony Brewer, CEO has patiently built up this new business and now they are NO.1 would expect profits to increase significantly

#CKN - Trading significantly ahead of expectations

#KMR - confirms they have received a non binding proposal from International Resource Holdings about a possible cash offer.

#JDW Decent performance in tough markets, helped by good summer weather. Chair Tim Martin articulates his thoughts on the case for a VAT cut for the hospitality sector - will the government listen?

#CPI - Updates on CSPS. Improvements made in August and September but still more to do. NAO doing their job and reviewing the administration

#SKL - Another excellent set of results from Skilcast Reiterates FY to be inline with mkt expectations

#OBI - Excellent interims with revenues up 23% Next 12 months all about gaining FDA approval, entering largest health market and growing sales in ROW. Funds in place to mid Q4. Announces opening Capital Access Window. Shares suspended

#SAGA - Trading ahead of expectations. FY PBT "to be materially higher than in the prior year and in the range of £65-70m." Medium term £100m PBT target expected to be achieved earlier than 2030 target. Turnaround is really gaining momentum

#FVA - Trading ahead of expectations, EBIT +60% and medium term target of £120m revenues and 10% EBIT margins reiterated. Mgmt are impressive and have a clear strategy for growth

#BILN - Excellent interims from Billington. Sad to see Mark Smith retire but he leaves the company in a good position. "enters the second half with a record order book and excellent visibility into 2027 and, for certain projects, into 2028. "

#OBI Great tie up with Mela which should accelerate penetration of NHS ICU facilities in the UK.

#MAB - stronger LFL's in Q4 mean confident FY will be in line. FY27 cost pressures to mitigate and further profit growth expected. Is it time for MAB to return to the #dividend list?